Similar articles

• Differential myocardial abundance of collagen type I and type III mRNA in dilated cardiomyopathy: effects of myocardial inflammation.

  Pauschinger M, Doerner A, Remppis A, Tannhäuser R, Kühl U, Schultheiss HP. Pauschinger M, et al. Cardiovasc Res. 1998 Jan;37(1):123-9. doi: 10.1016/s0008-6363(97)00217-4. Cardiovasc Res. 1998. PMID: 9539866
• Myocardial osteopontin expression is associated with collagen fibrillogenesis in human dilated cardiomyopathy.

  Satoh M, Nakamura M, Akatsu T, Shimoda Y, Segawa I, Hiramori K. Satoh M, et al. Eur J Heart Fail. 2005 Aug;7(5):755-62. doi: 10.1016/j.ejheart.2004.10.019. Eur J Heart Fail. 2005. PMID: 16087132
• Collagen content, but not the ratios of collagen type III/I mRNAs, differs among hypertensive, alcoholic, and idiopathic dilated cardiomyopathy.

  Soufen HN, Salemi VM, Aneas IM, Ramires FJ, Benício AM, Benvenuti LA, Krieger JE, Mady C. Soufen HN, et al. Braz J Med Biol Res. 2008 Dec;41(12):1098-104. doi: 10.1590/s0100-879x2008001200009. Braz J Med Biol Res. 2008. PMID: 19148372
• Transforming growth factor-beta(1) expression in dilated cardiomyopathy.

  Sanderson JE, Lai KB, Shum IO, Wei S, Chow LT. Sanderson JE, et al. Heart. 2001 Dec;86(6):701-8. doi: 10.1136/heart.86.6.701. Heart. 2001. PMID: 11711472 Free PMC article. No abstract available.
• Immunopathogenesis of dilated cardiomyopathy. Evidence for the role of TH2-type CD4+T lymphocytes and association with myocardial HLA-DR expression.

  Kuethe F, Braun RK, Foerster M, Schlenker Y, Sigusch HH, Kroegel C, Figulla HR. Kuethe F, et al. J Clin Immunol. 2006 Jan;26(1):33-9. doi: 10.1007/s10875-006-7585-x. J Clin Immunol. 2006. PMID: 16418801